MedPath

BIAXIN

BIAXIN

Approved
DIN Number

02244641

Drug Class

Human

Market Date

May 28, 2002

Company
HC

BGP Pharma ULC

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02244641
AIG Number0123752004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01FA09 CLARITHROMYCIN
Product Specifications
Dosage FormGranules For Suspension
Route of AdministrationOral
AHFS Classification08:12.12.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

CLARITHROMYCINActive
Strength: 250 MG / 5 ML
Monograph: CLARITHROMYCIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.